XML 75 R55.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY - Stock Options (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2022
USD ($)
tranche
$ / shares
shares
Dec. 31, 2020
$ / shares
Dec. 31, 2021
shares
Stock-based compensation      
Outstanding common stock (in shares) | shares 478,152    
Number of tranches | tranche 3    
Weighted average exercise price | $ / shares $ 28.32    
Options exercisable | shares 0   0
Outstanding at the end of the period 4 years 2 months 12 days    
Tranche One      
Stock-based compensation      
Outstanding common stock (in shares) | shares 159,384    
Weighted average exercise price | $ / shares $ 18.91    
Tranche Two      
Stock-based compensation      
Outstanding common stock (in shares) | shares 159,384    
Weighted average exercise price | $ / shares $ 28.23    
Tranche Three      
Stock-based compensation      
Outstanding common stock (in shares) | shares 159,384    
Weighted average exercise price | $ / shares $ 37.83    
Stock options      
Stock-based compensation      
Weighted average grant date fair value of grants | $ / shares   $ 3.36  
2020 Incentive Plan | Stock options      
Stock-based compensation      
Vesting period 4 years    
Percentage of awards vesting on the annual anniversary date of the grant 0.25    
Expiration term 7 years    
Unrecognized compensation expense stock option | $ $ 0.2    
Weighted average remaining vesting period 8 months 12 days